Halozyme Therapeutics
HALO
Teradata Corp
TDC
YETI Holdings
YETI
4
Cars.com
CARS
5
Constellation Brands
STZ
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -9.27%85.09M | -7.44%22.37M | 2.04%20.48M | -14.78%21.69M | -14.71%20.55M | -7.11%93.78M | -18.52%24.17M | -20.36%20.08M | 5.04%25.45M | 10.21%24.09M |
Operating revenue | -9.27%85.09M | -7.44%22.37M | 2.04%20.48M | -14.78%21.69M | -14.71%20.55M | -7.11%93.78M | -18.52%24.17M | -20.36%20.08M | 5.04%25.45M | 10.21%24.09M |
Cost of revenue | -10.84%44.02M | -0.99%12.36M | -4.27%10.44M | -19.78%10.81M | -16.74%10.41M | -1.76%49.37M | -20.71%12.48M | -15.83%10.91M | 19.24%13.48M | 21.99%12.51M |
Gross profit | -7.53%41.07M | -14.33%10.02M | 9.54%10.04M | -9.15%10.88M | -12.51%10.13M | -12.41%44.41M | -16.05%11.69M | -25.15%9.17M | -7.37%11.97M | -0.21%11.58M |
Operating expense | -12.90%110.03M | -19.47%25.01M | -9.84%27.16M | -12.95%27.92M | -9.49%29.94M | -8.32%126.33M | -6.52%31.05M | -14.13%30.12M | -12.70%32.07M | 1.00%33.08M |
Selling and administrative expenses | -9.36%77.58M | -6.27%19.41M | -5.34%19.31M | -13.43%18.86M | -11.87%20.01M | -10.28%85.59M | -6.76%20.71M | -17.28%20.4M | -17.32%21.79M | 2.31%22.7M |
-Selling and marketing expense | -16.28%31.67M | -23.80%7.16M | -0.61%8.14M | -11.79%8.53M | -25.83%7.84M | -15.89%37.83M | -4.83%9.39M | -30.46%8.19M | -24.91%9.67M | 1.23%10.58M |
-General and administrative expense | -3.88%45.91M | 8.29%12.25M | -8.52%11.16M | -14.74%10.33M | 0.31%12.17M | -5.29%47.76M | -8.29%11.31M | -5.21%12.2M | -10.08%12.12M | 3.28%12.13M |
Research and development costs | -20.36%32.44M | -45.89%5.6M | -19.27%7.85M | -11.92%9.06M | -4.29%9.94M | -3.89%40.74M | -6.04%10.35M | -6.69%9.72M | -0.97%10.29M | -1.77%10.38M |
Operating profit | 15.82%-68.96M | 22.58%-14.99M | 18.32%-17.11M | 15.21%-17.04M | 7.86%-19.81M | 5.94%-81.91M | -0.36%-19.36M | 8.22%-20.95M | 15.60%-20.1M | -1.65%-21.5M |
Net non-operating interest income expense | -43.52%3.4M | -82.43%246K | -42.24%852K | -27.45%1.06M | -26.32%1.25M | 110.22%6.03M | -6.54%1.4M | 46.91%1.48M | 323.48%1.46M | 8,355.00%1.69M |
Non-operating interest income | -33.56%4.25M | -60.72%601K | -36.27%1.02M | -22.00%1.23M | -17.21%1.4M | 122.38%6.4M | 2.14%1.53M | 59.24%1.6M | 345.48%1.58M | 8,355.00%1.69M |
Non-operating interest expense | 127.35%848K | 173.08%355K | 33.07%169K | 46.55%170K | --154K | 3,290.91%373K | --130K | 6,250.00%127K | 1,188.89%116K | --0 |
Other net income (expense) | 24.80%-21.26M | -38.97%2.3M | 77.28%-7.3M | 284.46%1.31M | -2,315.01%-17.57M | -148.39%-28.27M | -43.24%3.77M | -2,709.97%-32.12M | -102.57%-708K | -96.87%793K |
Gain on sale of security | -59.96%189K | --0 | 167.02%63K | -24.00%95K | -83.60%31K | -68.22%472K | -4.55%252K | 79.02%-94K | -87.19%125K | -72.73%189K |
Special income (charges) | 24.80%-21.38M | -26.21%2.62M | 75.50%-7.83M | 258.51%1.3M | -2,261.01%-17.46M | -149.61%-28.43M | -43.95%3.55M | -4,773.32%-31.97M | -103.06%-817K | -96.75%808K |
-Less:Restructuring and merger&acquisition | 453.09%3.66M | 26.21%-2.62M | 196.08%7.41M | -258.51%-1.3M | 119.93%161K | 98.19%-1.04M | 43.95%-3.55M | 281.40%2.5M | 103.06%817K | 96.75%-808K |
-Less:Impairment of capital assets | --0 | --0 | --0 | ---- | ---- | --29.47M | --0 | --29.47M | ---- | ---- |
-Less:Other special charges | --17.72M | --0 | --423K | ---- | --17.3M | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 78.83%-65K | -956.67%-317K | 956.36%471K | -425.00%-84K | 33.82%-135K | 19.42%-307K | -162.50%-30K | -41.03%-55K | 90.64%-16K | 6.85%-204K |
Income before tax | 16.65%-86.81M | 12.32%-12.45M | 54.34%-23.56M | 24.14%-14.68M | -89.98%-36.13M | -303.60%-104.15M | -27.23%-14.19M | -124.65%-51.6M | -574.28%-19.35M | -548.75%-19.02M |
Income tax | -112.12%-1.24M | -14,925.00%-593K | 19.31%-188K | 22.35%-278K | -18,500.00%-184K | -40.19%-586K | 100.94%4K | -7,866.67%-233K | -9,050.00%-358K | 200.00%1K |
Net income | 17.38%-85.57M | 16.52%-11.85M | 54.50%-23.37M | 24.17%-14.4M | -89.00%-35.95M | -307.94%-103.57M | -32.30%-14.2M | -123.60%-51.36M | -565.96%-18.99M | -548.67%-19.02M |
Net income continuous Operations | 17.38%-85.57M | 16.52%-11.85M | 54.50%-23.37M | 24.17%-14.4M | -89.00%-35.95M | -307.94%-103.57M | -32.30%-14.2M | -123.60%-51.36M | -565.96%-18.99M | -548.67%-19.02M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 17.38%-85.57M | 16.52%-11.85M | 54.50%-23.37M | 24.17%-14.4M | -89.00%-35.95M | -307.94%-103.57M | -32.30%-14.2M | -123.60%-51.36M | -565.96%-18.99M | -548.67%-19.02M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 17.38%-85.57M | 16.52%-11.85M | 54.50%-23.37M | 24.17%-14.4M | -89.00%-35.95M | -307.94%-103.57M | -32.30%-14.2M | -123.60%-51.36M | -565.96%-18.99M | -548.67%-19.02M |
Basic earnings per share | 19.77%-4.22 | 21.13%-0.56 | 55.77%-1.15 | 30.00%-0.7 | -80.00%-1.8 | -304.62%-5.26 | -42.00%-0.71 | -116.67%-2.6 | -600.00%-1 | -600.00%-1 |
Diluted earnings per share | 19.77%-4.22 | 21.13%-0.56 | 55.77%-1.15 | 30.00%-0.7 | -80.00%-1.8 | -304.62%-5.26 | -42.00%-0.71 | -116.67%-2.6 | -600.00%-1 | -600.00%-1 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |